Business1% match
Irvine Biotech Eledon Reports Positive Trial Data, Receives FDA Fast Track Designation
The Company's Investigational Drug, Tegoprubart, Designed to Prevent Organ Transplant Rejection, Showed Improved Patient Outcomes in Updated Phase 2 Trial Results.
Sep 22, 2026